Company news

Adhera Therapeutics Inc. news in 2015

Adhera Therapeutics Inc.'s news releases, calls and decks from 2015, newest first.

View company

Marina Biotech Reports Clinical and Preclinical Updates From SMARTICLES(R) Licensees Mirna Therapeutics and MiNA Therapeutics

November 19, 2015

Marina Biotech Receives Milestone Payment From SMARTICLES Licensee MiNA Therapeutics

November 17, 2015

Marina Biotech Announces Third Quarter 2015 Financial Results

November 16, 2015

Marina Biotech Reports That Licensee ProNAi Therapeutics Initiates 'Brighton' Phase II Trial of PNT2258 in Patients With Richter's Transformation

November 3, 2015

Marina Biotech and Hongene Biotechnology Announce License Agreement

September 28, 2015

Marina Biotech Announces Second Quarter 2015 Financial Results

August 13, 2015

Marina Biotech Announces $1.1 MM Convertible Preferred Stock Financing

August 6, 2015

Marina Biotech's CEQ508 Granted FDA Fast Track Designation for Familial Adenomatous Polyposis

August 5, 2015

Marina Biotech Expands European and Canadian Patent Protection of Its SMARTICLES Nucleic Acid Delivery Technology

June 10, 2015

Marina Biotech Announces SMARTICLES(R)-Mediated Delivery of a Double-Stranded Oligonucleotide to Immune Cells

May 5, 2015

Marina Biotech Expands Global Patent Protection of Clinical Stage Nucleic Acid Delivery Technologies

April 23, 2015

Marina Biotech Provides 2014 Year-End Financials and Update

February 25, 2015

Decks in 2015